Literature DB >> 2837065

Tarsorraphy in the treatment of persistent corneal lesions.

M Pakarinen1, T Tervo, A Tarkkanen.   

Abstract

Altogether 38 tarsorraphies were carried out to 19 patients with corneal epithelial defects resistant to conventional therapy. The main operative indications were lagothalmos, dry eyes and inadequate blinking (6 patients). Corneal ulcer was detected in 17 eyes, six of which perforated. All patients had been treated from one week to 16 months (mean 3.5 months) without healing. Retarsorraphy was needed in 6 eyes. In perforations tarsorraphy was combined to tissue adhesive (3 eyes) or to therapeutic contact lens (4 eyes) or to conjunctival flap (2 eyes). The corneal epithelium healed in all except 2 cases (one perforation, one ulcer that is slowly improving). Five of the 6 perforations could also be cured without grafting. One eye of a severely debilitated patient was treated with a Gundersen's conjunctival flap and total tarsorraphy, but remained hazy. We consider, that tarsorraphy is valuable in treating corneal lesions due to lagophthalmos, dry eyes or disturbed lid function. It can also be used in threatening of manifest corneal perforation, if combined with the use of tissue adhesive or therapeutic contact lens.

Entities:  

Mesh:

Year:  1987        PMID: 2837065     DOI: 10.1111/j.1755-3768.1987.tb02595.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Suppl


  5 in total

1.  Dry eye symptoms are increased in mice deficient in phospholipid transfer protein (PLTP).

Authors:  Niko L Setälä; Jari Metso; Matti Jauhiainen; Antti Sajantila; Juha M Holopainen
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK user group.

Authors:  Valerie P J Saw; Darwin Minassian; John K G Dart; Andrew Ramsay; Hugo Henderson; Stefan Poniatowski; Ruth M Warwick; Suzanne Cabral
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

Review 3.  Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone.

Authors:  Barbara Wirostko; MaryJane Rafii; David A Sullivan; Julia Morelli; Juan Ding
Journal:  Ocul Surf       Date:  2015-03-28       Impact factor: 5.033

4.  Outcomes of Infectious versus Sterile Perforated Corneal Ulcers after Therapeutic Penetrating Keratoplasty in the United States.

Authors:  Sloan W Rush; Ryan B Rush
Journal:  J Ophthalmol       Date:  2016-12-13       Impact factor: 1.909

5.  Commentary: Tarsorrhaphy: A stitch in time.

Authors:  Manisha Acharya; Abha Gour; Abhishek Dave
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.